electroCore ECOR
NASDAQ ECOR
$10.19 -0.62 (-5.69%)
At close: Aug 20, 2026 · 12:08 PM UTC

electroCore (ECOR) Restructuring Costs (2019 - 2020)

electroCore (ECOR) posted quarterly Restructuring Costs of $99606.0 for Q2 2020, down 88.28% year-over-year from $849792.0 in Q3 2019, and down 72.71% quarter-over-quarter from $365000.0 in Q1 2020.

electroCore (ECOR) Restructuring Costs (2019 - 2020) Analysis & Trends

electroCore's Restructuring Costs history runs 2 years deep, the most recent figure standing at $99606.0 for Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 200.19 Bn 194.59 Bn 7.27 Bn
2 Stryker 129.95 Bn 126.47 Bn 4.50 Bn
3 Medtronic 120.06 Bn 110.84 Bn 6.41 Bn
4 Boston Scientific 74.14 Bn 73.60 Bn 3.85 Bn
5 Edwards Lifesciences 52.74 Bn 48.49 Bn 1.35 Bn
6 Dexcom 34.60 Bn 32.65 Bn 830.00 Mn
7 GE HealthCare Technologies 34.20 Bn 32.10 Bn 2.18 Bn
8 Koninklijke Philips 26.46 Bn 23.13 Bn 4.55 Bn
9 Steris 23.25 Bn 22.77 Bn 684.20 Mn
10 electroCore 94.98 Mn 84.94 Mn 8.18 Mn

Historic Data

Download Data
DateValue
Jun 30, 2020 99,606.00
Mar 31, 2020 365,000.00
Jun 30, 2019 849,792.00